The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities
Background: The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored. Methods: Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and...
Saved in:
| Published in | Journal of oral pathology & medicine Vol. 31; no. 2; pp. 109 - 116 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Science, Ltd
01.02.2002
Blackwell |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0904-2512 1600-0714 |
| DOI | 10.1046/j.0904-2512.2001.00015.x |
Cover
| Abstract | Background: The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored.
Methods: Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high‐performance liquid chromatography, and the relationship between excretion levels and plasma protein‐binding activities of the antibiotics was investigated.
Results: Following addition of 50 µg/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 ± 1.2, 70.8 ± 0.8, 36.2 ± 0.5 and 8.3 ± 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 ± 0.5, 62.1 ± 1.4, 54.0 ± 0.8 and 6.0 ± 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 µg/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs.
Conclusion: These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment. |
|---|---|
| AbstractList | Background: The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored.
Methods: Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high‐performance liquid chromatography, and the relationship between excretion levels and plasma protein‐binding activities of the antibiotics was investigated.
Results: Following addition of 50 µg/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 ± 1.2, 70.8 ± 0.8, 36.2 ± 0.5 and 8.3 ± 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 ± 0.5, 62.1 ± 1.4, 54.0 ± 0.8 and 6.0 ± 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 µg/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs.
Conclusion: These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment. The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored.BACKGROUNDThe excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored.Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high-performance liquid chromatography, and the relationship between excretion levels and plasma protein-binding activities of the antibiotics was investigated.METHODSExcretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high-performance liquid chromatography, and the relationship between excretion levels and plasma protein-binding activities of the antibiotics was investigated.Following addition of 50 microgram/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 +/- 1.2, 70.8 +/- 0.8, 36.2 +/- 0.5 and 8.3 +/- 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 +/- 0.5, 62.1 +/- 1.4, 54.0 +/- 0.8 and 6.0 +/- 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 microgram/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs.RESULTSFollowing addition of 50 microgram/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 +/- 1.2, 70.8 +/- 0.8, 36.2 +/- 0.5 and 8.3 +/- 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 +/- 0.5, 62.1 +/- 1.4, 54.0 +/- 0.8 and 6.0 +/- 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 microgram/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs.These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment.CONCLUSIONThese results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment. The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that have not been fully explored. Excretion of four cephem antibiotics into saliva was examined in healthy volunteers and rats, using high-performance liquid chromatography, and the relationship between excretion levels and plasma protein-binding activities of the antibiotics was investigated. Following addition of 50 microgram/ml of each antibiotic to human plasma, protein binding rates (PBRs) of cefuzonam (CZON, molecular weight (MW): 535.58), cefotaxime (CTX, MW: 477.45), flomoxef (FMOX, MW: 518.45) and cefozopran (CZOP, MW: 551.99) were 87.8 +/- 1.2, 70.8 +/- 0.8, 36.2 +/- 0.5 and 8.3 +/- 0.3%, respectively. In rat plasma, PBRs of the four antibiotics were 94.0 +/- 0.5, 62.1 +/- 1.4, 54.0 +/- 0.8 and 6.0 +/- 0.8%, respectively. Similar PBRs were observed when the antibiotic concentration was increased to 100 and 200 microgram/ml. CZOP was most rapidly excreted into saliva and had the highest concentration in saliva among the tested antibiotics, while the plateau level of CZON was the lowest. The excreted levels of each antibiotic in saliva, when locally perfused through the rat facial artery, were inversely associated with each PBR. Similarly, the ratios of antibiotic concentration in saliva to rat plasma were almost constant for each antibiotic, revealing an inverse relationship with PBRs. These results appear to indicate that low molecular weight antibiotics are excreted into saliva through passive diffusion, inversely relating to their PBRs, and that high concentrations of antibiotics in the saliva have the potential to change the oral ecological environment. |
| Author | Kodama, Hiroyuki Hamada, Toshihiro Osaki, Tokio Ueta, Eisaku |
| Author_xml | – sequence: 1 givenname: Toshihiro surname: Hamada fullname: Hamada, Toshihiro organization: Department of Oral Surgery – sequence: 2 givenname: Eisaku surname: Ueta fullname: Ueta, Eisaku organization: Department of Oral Surgery – sequence: 3 givenname: Hiroyuki surname: Kodama fullname: Kodama, Hiroyuki organization: Department of Chemistry, Kochi Medical School, Kochi, Japan – sequence: 4 givenname: Tokio surname: Osaki fullname: Osaki, Tokio organization: Department of Oral Surgery |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13606222$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11896833$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkV1v0zAUQC00xLrBX0B-gbdk_kji9AWEJjaGBkNoaI_WjXNDb8lHsd2u_fcktGwST3uxZencY8vnhB31Q4-McSlSKbLibJmKucgSlUuVKiFkKsYlT7fP2EwWQiTCyOyIzR6gY3YSwnJkjM7kC3YsZTkvSq1nLN4ukOPWeYw09HxouMPVAjsOfaSKhkgucOrjwAO0tAFO03GDPmC74xDC4Agi1vye4oLHBZLnqxZCB3zlh4jUJxX1NfU_ObhIG4qE4SV73kAb8NVhP2U_Lj7enn9Krm8ur84_XCcu0_k8wSZTRiCWpsxyMDlAVkpZGV3mtWvqrCnAFE2uq1I0SlQud6I0jTBKj3htnD5lb_fe8Sm_1xii7Sg4bFvocVgHa2Q-urQZwdcHcF11WNuVpw78zv77pxF4cwAgOGgbD72j8MjpQhRKqZEr95zzQwgem0dE2CmdXdqpip2q2Cmd_ZvObsfRd_-NOoowVYkeqH2K4P1ecE8t7p58sf18801LocR8NCR7A4WI2wcD-F-2MNrk9u7rpf3-5e7CSGWs1n8A5JLCyg |
| CitedBy_id | crossref_primary_10_3390_ijms25021105 crossref_primary_10_1007_s11095_020_02977_8 crossref_primary_10_1016_j_joms_2013_06_214 crossref_primary_10_1097_j_pain_0000000000000498 crossref_primary_10_5649_jjphcs_37_335 crossref_primary_10_1016_j_joms_2012_01_007 crossref_primary_10_3390_antibiotics11040456 |
| Cites_doi | 10.1111/j.1365-2125.1995.tb04479.x 10.1016/0006-2952(81)90151-9 10.1016/S0003-9969(99)00044-8 10.1152/jappl.1975.39.4.519 10.1128/jcm.33.2.432-439.1995 10.1128/IAI.68.2.651-657.2000 10.1093/clinchem/23.2.157 10.1016/S0901-5027(05)80425-4 10.1002/(SICI)1099-081X(199905)20:4<183::AID-BDD178>3.0.CO;2-B 10.1111/j.1600-0714.1996.tb01221.x 10.1016/0378-4347(92)80616-X 10.1111/j.1600-0714.1990.tb00809.x 10.1177/00220345990780030801 10.1097/00000441-199909000-00009 10.2165/00003088-199936060-00006 10.1002/ar.1092210404 10.1016/0306-3623(85)90082-5 10.1016/S0026-895X(25)14597-5 |
| ContentType | Journal Article |
| Copyright | 2002 INIST-CNRS |
| Copyright_xml | – notice: 2002 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1046/j.0904-2512.2001.00015.x |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Dentistry |
| EISSN | 1600-0714 |
| EndPage | 116 |
| ExternalDocumentID | 11896833 13606222 10_1046_j_0904_2512_2001_00015_x JOP310209 ark_67375_WNG_RMWF7127_3 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OB 1OC 29L 31~ 33P 34H 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CWXXS D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 UDS V8K W8V W99 WBKPD WBNRW WIH WIJ WIK WOHZO WPGGZ WQJ WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE WRC AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c4359-ef4270ee87845a75aa4811b7385dcfd4f6a76f53b80f20bc5c087f072345ad7c3 |
| IEDL.DBID | DR2 |
| ISSN | 0904-2512 |
| IngestDate | Wed Oct 01 14:09:46 EDT 2025 Wed Feb 19 02:08:43 EST 2025 Mon Jul 21 09:15:49 EDT 2025 Wed Oct 01 06:41:32 EDT 2025 Thu Apr 24 22:56:17 EDT 2025 Wed Jan 22 16:27:39 EST 2025 Sun Sep 21 06:18:59 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Human High performance Plasma Correlation Excretion Healthy subject Rat Rodentia Activity Exploration Experimental study Chromatography Liquid Binding protein Vertebrata Antibiotic Mammalia Animal Clinical trial Pharmacokinetics Saliva |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4359-ef4270ee87845a75aa4811b7385dcfd4f6a76f53b80f20bc5c087f072345ad7c3 |
| Notes | istex:F01671CD092A4047AD7F5CC94B887FD47D9F0D0F ArticleID:0015 ark:/67375/WNG-RMWF7127-3 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 11896833 |
| PQID | 71538537 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_71538537 pubmed_primary_11896833 pascalfrancis_primary_13606222 crossref_primary_10_1046_j_0904_2512_2001_00015_x crossref_citationtrail_10_1046_j_0904_2512_2001_00015_x wiley_primary_10_1046_j_0904_2512_2001_00015_x_JOP310209 istex_primary_ark_67375_WNG_RMWF7127_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | February 2002 |
| PublicationDateYYYYMMDD | 2002-02-01 |
| PublicationDate_xml | – month: 02 year: 2002 text: February 2002 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Denmark |
| PublicationTitle | Journal of oral pathology & medicine |
| PublicationTitleAlternate | J Oral Pathol Med |
| PublicationYear | 2002 |
| Publisher | Blackwell Science, Ltd Blackwell |
| Publisher_xml | – name: Blackwell Science, Ltd – name: Blackwell |
| References | Briand C, Sarrazin M, Peyrot V, Gilli R, Bourdeaux M, Sari JC. Study of the interaction between human serum albumin and some cephalosporins. Mol Pharmacol 1982; 21: 92-9. Irwin D, Mande I. The diagnostic uses of saliva. J Oral Pathol Med 1990; 19: 119-25. Fehske KJ, Muller WE, Wollert U. The location of drug binding sites in human serum albumin. Biochem Pharmacol 1981; 30: 687-92. Tomita Y, Osaki T. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment. Int J Oral Maxillofac Surg 1990; 19: 299-304. Fidel PL Jr, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun 2000; 68: 651-7. Akimoto Y, Nishimura H, Komiya M, et al. Concentrations of ampicillin and cefadroxil in human serum and mixed saliva following a single oral administration of talampicillin and cefadroxil, and relationships between serum and mixed saliva concentrations. Gen Pharmacol 1985; 6: 273-5. Nauntofte B. Regulation of electrolyte and fluid secretion in salivary acinar cells. Am J Physiol 1992; 263: G823-37. Schneyer LH, Flatland RF. Evaluation of a reservoir in the main excretory duct of rat submaxillary gland. J Appl Physiol 1975; 39: 519-22. Turner RJ, Paulais M, Valdez II, Evans RL, Fox PC. Ion transport and signalling in human labial glands. Arch Oral Biol 1999; 44: S15-9. Schneeberger EE, Lynch RD. Structure, function, regulation of cellular tight junctions. Am J Physiol 1992; 262: L647-61. Kozjek F, Suturkova LJ, Antolic G, Grabnar I, Mrhar A. Kinetics of 4-fluoroquinolones permeation into saliva. Biopharm Drug Dispos 1999; 20: 183-91. Horning MG, Brown L, Nowlin J, Lertratanangkoon K, Kellaway P, Zion TE. Use of saliva in therapeutic drug monitoring. Clin Chem 1977; 23: 157-64. Umazume M, Ueta E, Osaki T. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol 1995; 33: 432-9. Liu H, Delgado MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet 1999; 36: 453-70. Dougall HT, Smith L, Duncan C, Benjamin N. The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmacol 1995; 39: 460-2. Osaki T, Ohshima M, Tomita Y, Matsugi N, Nomura Y. Clinical and physiological investigations in patients with taste abnormality. J Oral Pathol Med 1996; 25: 38-43. Lotti LV, Hand AR. Endocytosis of parotid salivary proteins by striated duct cells in streptozocin-diabetic rats. Anat Rec 1988; 221: 802-11. Rudney JD, Hickey KL, Ji Z. Cumulative correlations of lysozome, lactoferrin, peroxidase, S-IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva. J Dent Res 1999; 78: 759-68. Haeckel R, Hänecke P. Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem 1996; 34: 171-91. Hamada T, Nakane T, Kimura T, et al. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci 1999; 318: 146-51. Yamashita K, Motohashi M, Yashiki T. Automated high-perfomance liquid chromatographic method for the simultaneous determination of cefotiam and delta 3-cefotiam in human plasma using column switching. J Chromatogr 1992; 577: 174-9. 1995; 39 1992; 262 1992; 263 2000; 68 1990; 19 1975; 39 1995; 33 1982; 21 1999; 36 1992; 577 1985; 6 1999; 78 1999; 44 1988; 221 1999; 20 1977; 23 1996; 25 1981; 30 1996; 34 1999; 318 e_1_2_5_14_2 e_1_2_5_13_2 e_1_2_5_9_2 e_1_2_5_16_2 Schneeberger EE (e_1_2_5_17_2) 1992; 262 e_1_2_5_15_2 Nauntofte B (e_1_2_5_10_2) 1992; 263 e_1_2_5_22_2 e_1_2_5_6_2 e_1_2_5_5_2 e_1_2_5_20_2 e_1_2_5_4_2 e_1_2_5_11_2 Umazume M (e_1_2_5_2_2) 1995; 33 e_1_2_5_3_2 e_1_2_5_18_2 e_1_2_5_19_2 Haeckel R (e_1_2_5_7_2) 1996; 34 Briand C (e_1_2_5_21_2) 1982; 21 Horning MG (e_1_2_5_8_2) 1977; 23 Schneyer LH (e_1_2_5_12_2) 1975; 39 |
| References_xml | – reference: Liu H, Delgado MR. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Clin Pharmacokinet 1999; 36: 453-70. – reference: Lotti LV, Hand AR. Endocytosis of parotid salivary proteins by striated duct cells in streptozocin-diabetic rats. Anat Rec 1988; 221: 802-11. – reference: Osaki T, Ohshima M, Tomita Y, Matsugi N, Nomura Y. Clinical and physiological investigations in patients with taste abnormality. J Oral Pathol Med 1996; 25: 38-43. – reference: Schneeberger EE, Lynch RD. Structure, function, regulation of cellular tight junctions. Am J Physiol 1992; 262: L647-61. – reference: Rudney JD, Hickey KL, Ji Z. Cumulative correlations of lysozome, lactoferrin, peroxidase, S-IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva. J Dent Res 1999; 78: 759-68. – reference: Fehske KJ, Muller WE, Wollert U. The location of drug binding sites in human serum albumin. Biochem Pharmacol 1981; 30: 687-92. – reference: Nauntofte B. Regulation of electrolyte and fluid secretion in salivary acinar cells. Am J Physiol 1992; 263: G823-37. – reference: Kozjek F, Suturkova LJ, Antolic G, Grabnar I, Mrhar A. Kinetics of 4-fluoroquinolones permeation into saliva. Biopharm Drug Dispos 1999; 20: 183-91. – reference: Umazume M, Ueta E, Osaki T. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol 1995; 33: 432-9. – reference: Turner RJ, Paulais M, Valdez II, Evans RL, Fox PC. Ion transport and signalling in human labial glands. Arch Oral Biol 1999; 44: S15-9. – reference: Tomita Y, Osaki T. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment. Int J Oral Maxillofac Surg 1990; 19: 299-304. – reference: Fidel PL Jr, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infect Immun 2000; 68: 651-7. – reference: Schneyer LH, Flatland RF. Evaluation of a reservoir in the main excretory duct of rat submaxillary gland. J Appl Physiol 1975; 39: 519-22. – reference: Akimoto Y, Nishimura H, Komiya M, et al. Concentrations of ampicillin and cefadroxil in human serum and mixed saliva following a single oral administration of talampicillin and cefadroxil, and relationships between serum and mixed saliva concentrations. Gen Pharmacol 1985; 6: 273-5. – reference: Irwin D, Mande I. The diagnostic uses of saliva. J Oral Pathol Med 1990; 19: 119-25. – reference: Briand C, Sarrazin M, Peyrot V, Gilli R, Bourdeaux M, Sari JC. Study of the interaction between human serum albumin and some cephalosporins. Mol Pharmacol 1982; 21: 92-9. – reference: Yamashita K, Motohashi M, Yashiki T. Automated high-perfomance liquid chromatographic method for the simultaneous determination of cefotiam and delta 3-cefotiam in human plasma using column switching. J Chromatogr 1992; 577: 174-9. – reference: Hamada T, Nakane T, Kimura T, et al. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci 1999; 318: 146-51. – reference: Horning MG, Brown L, Nowlin J, Lertratanangkoon K, Kellaway P, Zion TE. Use of saliva in therapeutic drug monitoring. Clin Chem 1977; 23: 157-64. – reference: Haeckel R, Hänecke P. Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem 1996; 34: 171-91. – reference: Dougall HT, Smith L, Duncan C, Benjamin N. The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmacol 1995; 39: 460-2. – volume: 36 start-page: 453 year: 1999 end-page: 70 article-title: Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants publication-title: Clin Pharmacokinet – volume: 34 start-page: 171 year: 1996 end-page: 91 article-title: Application of saliva for drug monitoring. An in vivo model for transmembrane transport publication-title: Eur J Clin Chem Clin Biochem – volume: 262 start-page: L647 year: 1992 end-page: 61 article-title: Structure, function, regulation of cellular tight junctions publication-title: Am J Physiol – volume: 263 start-page: G823 year: 1992 end-page: 37 article-title: Regulation of electrolyte and fluid secretion in salivary acinar cells publication-title: Am J Physiol – volume: 33 start-page: 432 year: 1995 end-page: 9 article-title: Reduced inhibition of albicans adhesion by saliva from patients receiving oral cancer therapy publication-title: J Clin Microbiol – volume: 25 start-page: 38 year: 1996 end-page: 43 article-title: Clinical and physiological investigations in patients with taste abnormality publication-title: J Oral Pathol Med – volume: 39 start-page: 460 year: 1995 end-page: 2 article-title: The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? publication-title: Br J Clin Pharmacol – volume: 39 start-page: 519 year: 1975 end-page: 22 article-title: Evaluation of a reservoir in the main excretory duct of rat submaxillary gland publication-title: J Appl Physiol – volume: 68 start-page: 651 year: 2000 end-page: 7 article-title: Effects of reproductive hormones on experimental vaginal candidiasis publication-title: Infect Immun – volume: 23 start-page: 157 year: 1977 end-page: 64 article-title: Use of saliva in therapeutic drug monitoring publication-title: Clin Chem – volume: 20 start-page: 183 year: 1999 end-page: 91 article-title: Kinetics of 4‐fluoroquinolones permeation into saliva publication-title: Biopharm Drug Dispos – volume: 30 start-page: 687 year: 1981 end-page: 92 article-title: The location of drug binding sites in human serum albumin publication-title: Biochem Pharmacol – volume: 221 start-page: 802 year: 1988 end-page: 11 article-title: Endocytosis of parotid salivary proteins by striated duct cells in streptozocin‐diabetic rats publication-title: Anat Rec – volume: 6 start-page: 273 year: 1985 end-page: 5 article-title: Concentrations of ampicillin and cefadroxil in human serum and mixed saliva following a single oral administration of talampicillin and cefadroxil, and relationships between serum and mixed saliva concentrations publication-title: Gen Pharmacol – volume: 78 start-page: 759 year: 1999 end-page: 68 article-title: Cumulative correlations of lysozome, lactoferrin, peroxidase, S‐IgA, amylase, and total protein concentrations with adherence of oral viridans streptococci to microplates coated with human saliva publication-title: J Dent Res – volume: 19 start-page: 299 year: 1990 end-page: 304 article-title: Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment publication-title: Int J Oral Maxillofac Surg – volume: 318 start-page: 146 year: 1999 end-page: 51 article-title: Treatment of xerostomia with the bile secretion‐stimulating drug anethole trithione: a clinical trial publication-title: Am J Med Sci – volume: 577 start-page: 174 year: 1992 end-page: 9 article-title: Automated high‐perfomance liquid chromatographic method for the simultaneous determination of cefotiam and delta 3‐cefotiam in human plasma using column switching publication-title: J Chromatogr – volume: 19 start-page: 119 year: 1990 end-page: 25 article-title: The diagnostic uses of saliva publication-title: J Oral Pathol Med – volume: 21 start-page: 92 year: 1982 end-page: 9 article-title: Study of the interaction between human serum albumin and some cephalosporins publication-title: Mol Pharmacol – volume: 44 start-page: S15 year: 1999 end-page: 9 article-title: Ion transport and signalling in human labial glands publication-title: Arch Oral Biol – ident: e_1_2_5_5_2 doi: 10.1111/j.1365-2125.1995.tb04479.x – volume: 34 start-page: 171 year: 1996 ident: e_1_2_5_7_2 article-title: Application of saliva for drug monitoring. An in vivo model for transmembrane transport publication-title: Eur J Clin Chem Clin Biochem – ident: e_1_2_5_20_2 doi: 10.1016/0006-2952(81)90151-9 – ident: e_1_2_5_9_2 doi: 10.1016/S0003-9969(99)00044-8 – volume: 39 start-page: 519 year: 1975 ident: e_1_2_5_12_2 article-title: Evaluation of a reservoir in the main excretory duct of rat submaxillary gland publication-title: J Appl Physiol doi: 10.1152/jappl.1975.39.4.519 – volume: 33 start-page: 432 year: 1995 ident: e_1_2_5_2_2 article-title: Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy publication-title: J Clin Microbiol doi: 10.1128/jcm.33.2.432-439.1995 – volume: 263 start-page: G823 year: 1992 ident: e_1_2_5_10_2 article-title: Regulation of electrolyte and fluid secretion in salivary acinar cells publication-title: Am J Physiol – ident: e_1_2_5_16_2 doi: 10.1128/IAI.68.2.651-657.2000 – volume: 23 start-page: 157 year: 1977 ident: e_1_2_5_8_2 article-title: Use of saliva in therapeutic drug monitoring publication-title: Clin Chem doi: 10.1093/clinchem/23.2.157 – ident: e_1_2_5_11_2 doi: 10.1016/S0901-5027(05)80425-4 – ident: e_1_2_5_18_2 doi: 10.1002/(SICI)1099-081X(199905)20:4<183::AID-BDD178>3.0.CO;2-B – ident: e_1_2_5_15_2 doi: 10.1111/j.1600-0714.1996.tb01221.x – ident: e_1_2_5_13_2 doi: 10.1016/0378-4347(92)80616-X – volume: 262 start-page: L647 year: 1992 ident: e_1_2_5_17_2 article-title: Structure, function, regulation of cellular tight junctions publication-title: Am J Physiol – ident: e_1_2_5_14_2 doi: 10.1111/j.1600-0714.1990.tb00809.x – ident: e_1_2_5_3_2 doi: 10.1177/00220345990780030801 – ident: e_1_2_5_4_2 doi: 10.1097/00000441-199909000-00009 – ident: e_1_2_5_6_2 doi: 10.2165/00003088-199936060-00006 – ident: e_1_2_5_19_2 doi: 10.1002/ar.1092210404 – ident: e_1_2_5_22_2 doi: 10.1016/0306-3623(85)90082-5 – volume: 21 start-page: 92 year: 1982 ident: e_1_2_5_21_2 article-title: Study of the interaction between human serum albumin and some cephalosporins publication-title: Mol Pharmacol doi: 10.1016/S0026-895X(25)14597-5 |
| SSID | ssj0017341 |
| Score | 1.6365092 |
| Snippet | Background: The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many... Background: The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many... The excretion of medicated drugs into saliva may disturb the oral environment and antibiotic excretion into saliva appears to be regulated by many factors that... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 109 |
| SubjectTerms | Adult Animals antibiotics Area Under Curve Biological and medical sciences Cefotaxime - administration & dosage Cefotaxime - blood Cefotaxime - pharmacokinetics Cefozopran Ceftizoxime - administration & dosage Ceftizoxime - analogs & derivatives Ceftizoxime - blood Ceftizoxime - pharmacokinetics Cephalosporins - administration & dosage Cephalosporins - blood Cephalosporins - pharmacokinetics Chromatography, High Pressure Liquid Diffusion excretion Female General pharmacology Humans Hydrogen-Ion Concentration Injections, Intravenous Kinetics Male Medical sciences Perfusion Pharmacokinetics. Pharmacogenetics. Drug-receptor interactions Pharmacology. Drug treatments Protein Binding protein binding activity Rats Rats, Sprague-Dawley saliva Saliva - metabolism Statistics, Nonparametric |
| Title | The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities |
| URI | https://api.istex.fr/ark:/67375/WNG-RMWF7127-3/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.0904-2512.2001.00015.x https://www.ncbi.nlm.nih.gov/pubmed/11896833 https://www.proquest.com/docview/71538537 |
| Volume | 31 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0904-2512 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1600-0714 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017341 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQOcCF9yNAiw-IWyI7dmLniKBLVakFVVTtzbITR0q3TarubrVw4if0N_aXMONkUy3qoULcEiWTx2Sc-eyZ-YaQD2nluXRFBSOtYDFsFbGuMh-rVFc5ePSahQW3vf1851DuHmfHQ_4T1sL0_BDjghuOjPC_xgFuXd-FhAV225OEFUzG6J9xmseTUBacIJ7kIg-zq4ORSYorEZpYjiJDUk8f4Lz9Qmue6j4qfYmZk3YGyqv7rhe3wdJ1lBvc1OQxma5esM9OmSaLuUvKX39xP_4fDTwhjwY0Sz_15veU3PPtM_LgC2YgYRO55-QSzJD6ZYm1kl1Lu5qWmFV2RuGDNq7pkCSaNu28ozOLQSna4C6mivjTn9QOtuMriuvFNEQ16DkA_jNLA8NE017_vnJNKM2hWKNxGRhiX5DDyfaPzzvx0OohLgGvFbGvZaqY91ppmVmVWSs15w6pdqqyrmSdW5XXmXCa1SlzZVYyrcCOUgGnV6oUL8lG27X-NaFOuVxbjHgKC8620lYCSnSiyH0Bh3hE1OqzmnLgQcd2HKcmxOMl1q6hXg3qFbt08hCgz8wyInyUPO-5QO4g8zFYzihgL6aYS6cyc7T_1RzsHU0UT5UREdlaM62bOwiYYwKKi8j7la0Z-AVgXMe2vlvMjEKvlQkVkVe9Cd7Icl3kWsDFdTCkOz-22f32HYB_yoo3_y76ljwMvXNCjvs7sjG_WPhNgHBztxUG5x9h3zXw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtNAEF6h9lAu_EMNtN0D4ubg9a696yOChlCagKpW7W21a68lq6ldNUkVOPEIPCNPwszacRXUQ4W4xUrGdsYznm93Zr4h5E1cOCZsVoCnZVEIn7JQFYkLZayKFCJ6GfkNt_EkHZ2Ig7PkrBsHhL0wLT9Ev-GGnuHf1-jguCH9rktLei-PskiEGKBxnccGvi94AIByU6SwbEGEdNRzSTHJ_RjLXqYr62lTnLefaS1WbaLal1g7aWagvrKde3EbMF3HuT5QDR-S6eovtvUp54PF3A7yH3-xP_4nHTwiDzpAS9-3FviY3HP1E7L1EYuQcI7cU3INlkjdMsd2yaamTUlzLCy7oPBMK1s1yBNNq3re0JnBvBSt8BCrRdz0OzWd-biC4pYx9YkNegmY_8JQTzJR1b9__rKV786h2KZx7Ulin5GT4f7xh1HYTXsIc4BsWehKEcvIOSWVSIxMjBGKMYtsO0VeFqJMjUzLhFsVlXFk8ySPlARTijn8vJA5f0426qZ224RaaVNlMOnJDcTbQhkBQNHyLHUZfMUCIlfPVecdFTpO5Jhqn5IX2L6GetWoVxzUyXyOPtHLgLBe8rKlA7mDzFtvOr2AuTrHcjqZ6NPJJ300Ph1KFkvNA7K7Zls3V-CwzAQgF5C9lbFpeAtgasfUrlnMtMTAlXAZkBetDd7IMpWlisPJlbekO9-2Pvj6DbB_HGUv_110j2yNjseH-vDz5Msrct-P0vEl76_Jxvxq4XYA0c3trvfUP9C4OhE |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELfQJgEv_GcExuYHxFtKnNix_YgoZQxWpolpe7Ps2JGidUm1tlPhiY_AZ-STzOekmYr2MCHeUqWXppe73M--u98h9Ca1jlAjrfc0mcT-SMbCMhfzVNjcR_QyCRtuB-N875jun7LTbhwQ9MK0_BD9hht4Rnhfg4O7qS3fdWnJ4OWJTGgMARrWeWQQ-oIHHlBuUiYF1PcNj3ouKcKzMMayl-nKetoU581XWotVm6D2JdRO6plXX9nOvbgJmK7j3BCoRg_RZPUX2_qUs8FibgbFz7_YH_-TDh6hBx2gxe9bC3yM7rj6Cbo3hCIkmCP3FF16S8RuWUC7ZFPjpsQFFJadY_9MK1M1wBONq3re4JmGvBSu4CNUi7jJD6w783EWw5YxDokNPPWY_1zjQDJR1X9-_TZV6M7B0KZxGUhin6Hj0cfvH_bibtpDXHjIJmNX0pQnzgkuKNOcaU0FIQbYdmxRWlrmmucly4xIyjQxBSsSwb0ppZn_uuVF9hxt1E3tXiBsuMmFhqRnpn28tUJTDxRNJnMn_SkSIb56rqroqNBhIsdEhZQ8hfY10KsCvcKgThJy9EwtI0R6yWlLB3ILmbfBdHoBfXEG5XScqZPxJ3V0cDLiJOUqi9DOmm1d_0Lml5keyEVod2Vsyr8FILWja9csZopD4GIZj9BWa4PXskTIXGT-4iJY0q1vW-1_O_TYP03ky38X3UV3D4cj9fXz-MsrdD9M0gkV79toY36xcK89oJubneCoVyiMOZU |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+excretion+of+cephem+antibiotics+into+saliva+is+inversely+associated+with+their+plasma+protein%E2%80%90binding+activities&rft.jtitle=Journal+of+oral+pathology+%26+medicine&rft.au=Hamada%2C+Toshihiro&rft.au=Ueta%2C+Eisaku&rft.au=Kodama%2C+Hiroyuki&rft.au=Osaki%2C+Tokio&rft.date=2002-02-01&rft.issn=0904-2512&rft.eissn=1600-0714&rft.volume=31&rft.issue=2&rft.spage=109&rft.epage=116&rft_id=info:doi/10.1046%2Fj.0904-2512.2001.00015.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1046_j_0904_2512_2001_00015_x |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0904-2512&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0904-2512&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0904-2512&client=summon |